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often made their views clear to 
us. But as this is a complex area 
of science, many other people 
might feel that they don’t know 
enough about the issue to take 
part in the debate or give their 
views.”
But many researchers were 
critical of the inevitable delays 
and perceived indecision on the 
part of the government and the 
HFEA. Harrison is keen, however, 
to stress the UK’s support for 
this research field. “Scientists 
tell me that one of the reasons 
they choose to carry out their 
research in the UK is because 
of the environment of public 
support and trust that we have. 
As a regulator, we certainly don’t 
want to hold research up without 
a cause, but it’s vital that we 
understand the broader public 
view on this new area of research 
to allow that support and trust to 
continue.”
Alongside this consultation 
process, a public meeting 
was held last month where a 
broad range of people, such 
as interest groups, fertility 
patients, members of the 
public and scientists, met to 
discuss the issues raised by 
the research in more depth. The 
meeting was chaired by a TV 
journalist experienced in chairing 
controversial debates who also 
has specialist knowledge of 
bioethics. Alongside the chair 
there was a panel of experts 
who could add their views to the 
discussion and answer a broad 
range of questions from the 
audience during the debate.
But while the HFEA consultation 
goes on, the public health minister 
Caroline Flint said: “Our aim 
in drafting this bill is to deliver 
a legislative framework that 
will allow legitimate medical 
and scientific uses of human 
reproductive technologies to 
continue to flourish in this country, 
while giving the public confidence 
in how they are being used and 
developed.”
Robin Lovell-Badge, at the 
National Institute for Medical 
Research said: “This research 
has many potential benefits for 
the understanding of disease and 
for treatments and should not be 
feared.”Germany is one of ten EU 
countries that explicitly ban 
production of human embryonic 
stem cells. In 2002, the 
Bundestag tried to draw a line 
under the heated discussion 
over the promises and ethical 
concerns with a compromise 
legislation that allowed import 
of stem-cell lines that had 
been created before January 1, 
2002. Five years later, however, 
researchers are clamouring 
for a change to the law, as any 
surviving cell lines from that time 
are now seriously out of date. In 
May, the new stem-cell debate 
moved to a parliamentary level, 
when the Bundestag committee 
in charge of education and 
research held a day-long debate 
on the issue. 
The funding agency Deutsche 
Forschungsgemeinschaft (DFG), 
representing researchers, 
proposed to scrap the date limit 
altogether and allow the import 
of all stem-cell lines available. 
Furthermore, the DFG would like 
to abolish the threat of prison 
sentences to researchers who 
take part in the creation of stem 
cells, arguing that the current 
legal situation creates insecurity 
among researchers who, via 
international collaborations, 
might be held responsible for 
actions that break German laws. 
On the other side of the 
trenches, several religious 
organisations are trying to 
defend the current version of the 
Embryonenschutzgesetz, or law 
for the protection of embryos. 
They argue that a removal of the 
time limit would allow German 
researchers to have embryos 
“killed on demand” abroad. 
The protestant bishop 
Wolfgang Huber has suggested 
a new compromise, namely 
moving the time limit closer to 
the present, which would give 
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Across the political parties, 
the positions are complicated. 
The small liberal party, FDP, 
currently in opposition, has 
handed in a draft legislation that 
would essentially follow the DFG 
suggestions and scrap the time 
limit. While this approach may 
find support in the Linkspartei 
(Left party) and parts of the 
governing social democratic SPD, 
it was criticized harshly by parts 
of Angela Merkel’s CDU, which 
is traditionally dominated by 
catholics, and by the Green Party. 
Similar divisions are even found 
within the government formed by 
SPD and CDU. Chancellor Angela 
Merkel, herself a scientist, has 
supported the efforts to update 
the legislation. Her research 
minister, Annette Schavan, 
however, is a committed catholic 
and would fiercely oppose 
unlimited import (let alone home 
production) of stem cells. She is 
said to be open to the compromise 
of shifting the time limit, but 
stated ahead of the committee 
meeting that she will “under no 
circumstances abolish it”.
Voters are equally divided. 
A snap poll just ahead of the 
committee meeting showed 
65% in favour of changing the 
law, but it appears unlikely that 
any drastic change could find a 
similar majority in the electorate, 
in parliament, or indeed in the 
government. 
Now that the conflicting views 
have been exchanged once more, 
it is up to Merkel’s government 
to find a way out of the dilemma. 
If she wants to avoid a rerun 
of the fierce public debate of 
2001/2002, she might end up 
taking the easiest way out of 
the dilemma, namely changing 
nothing but the date. If Christian 
critics could live with the date 
rule in 2002, chances are they will 
be able to live with a similar rule, 
only with a more recent date filled 
in, in 2007.
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